CBAN Stock Analysis: Colony Bankcorp | NYSE

Banks - Regional | NYSE, USA | Market Cap: 550m USD | 12M Return: 24.2% | US19623P1012 | Charts, Fundamentals & Technical Analysis

Deposit Accounts, Commercial Loans, Mortgage Lending, Wealth Management
Total Rating 33
Safety 34
Buy Signal -0.08
Regional Banks
Sub-Industry Rotation: +2.9
Market Cap: 550M
Avg Turnover: 3.33M
Risk 3d forecast
Volatility30.3%
VaR 5th Pctl4.29%
VaR vs Median-10.9%
Reward TTM
Sharpe Ratio0.90
Rel. Str. IBD58
Rel. Str. Peer Group32.4 pctl
Character TTM
Beta0.389
Beta Downside0.354
Hurst Exponent0.567
Choppyness59.9%
Drawdowns 3y
Max DD20.88%
CAGR/Max DD1.27
CAGR/Mean DD3.92
EPS (Earnings per Share) EPS (Earnings per Share) of CBAN over the last years for every Quarter: "2021-09": 0.57, "2021-12": 0.4, "2022-03": 0.37, "2022-06": 0.3, "2022-09": 0.3, "2022-12": 0.31, "2023-03": 0.31, "2023-06": 0.33, "2023-09": 0.34, "2023-12": 0.31, "2024-03": 0.33, "2024-06": 0.34, "2024-09": 0.35, "2024-12": 0.44, "2025-03": 0.38, "2025-06": 0.46, "2025-09": 0.47, "2025-12": 0.48, "2026-03": 0.45, "2026-06": 0.52, "2026-09": 0.54,
EPS CAGR: 19.46%
EPS Trend: 98.5%
Last SUE: 0.54
Qual. Beats: 0
Revenue Revenue of CBAN over the last years for every Quarter: 2021-09: 28.463, 2021-12: 31.017, 2022-03: 29.389, 2022-06: 31.23, 2022-09: 31.873, 2022-12: 34.07, 2023-03: 36.029, 2023-06: 39.716, 2023-09: 42.297, 2023-12: 42.508, 2024-03: 42.797, 2024-06: 42.833, 2024-09: 44.686, 2024-12: 46.3, 2025-03: 44.569, 2025-06: 46.933, 2025-09: 46.983, 2025-12: 51.747, 2026-03: 52.308, 2026-06: 7.905, 2026-09: 56.307,
Rev. CAGR: 2.46%
Rev. Trend: 33.1%
Last SUE: 0.53
Qual. Beats: 0

Warnings

Strong Share Dilution
Below Avwap Earnings
Below Sma 200d

Tailwinds

Confidence

Seasonality 11.6 years of data

Jan -1.7% 5
Feb -0.6% 5
Mar +1.7% 5
Apr -2.2% 46
May -0.5% 20
Jun +0.4% 19
Jul +0.1% 10
Aug -0.4% 13
Sep -1.0% 28
Oct -0.3% 2
Nov +6.6% 57
Dec +1.7% 11

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: CBAN Colony Bankcorp

Colony Bankcorp, Inc. (CBAN) is a U.S. bank holding company that operates through Colony Bank and three reporting segments: Bank, Mortgage Banking, and Small Business Specialty Lending. Founded in 1975 and headquartered in Fitzgerald, Georgia, the company delivers a broad suite of retail and commercial banking products, including checking, savings, money market, and certificate of deposit accounts, along with treasury solutions and merchant services.

The companys loan portfolio spans small and medium-sized business lending, commercial and residential real estate, construction and land development, agri-business, residential mortgages, home equity, consumer credit, marine/RV financing, and SBA and other government-guaranteed loans. Complementary offerings include wealth management, consumer and business insurance, digital and mobile banking, and various specialty lending programs such as healthcare, USDA, and equipment financing. As a community-focused regional bank, Colony Bankcorp relies on local deposit gathering and relationship-based lending rather than the capital-markets or investment banking activities typical of larger money-center institutions.

Headlines to Watch Out For
  • Net interest margin trends on Fed rate path
  • Small business specialty lending segment drives loan growth
  • Deposit costs rise amid regional Georgia banking competition
Piotroski VR-10 (Strict) 3.0
Net Income: 37.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.04 > 1.0
NWC/Revenue: -1.21k% < 20% (prev -1.20k%; Δ -9.31% < -1%)
CFO/TA 0.00 > 3% & CFO 15.2m > Net Income 37.4m
Net Debt (-629.3m) to EBITDA (28.8m): -21.82 < 3
Current Ratio: 0.31 > 1.5 & < 3
Outstanding Shares: last quarter (21.2m) vs 12m ago 21.45% < -2%
Gross Margin: 59.92% > 18% (prev 66.32%; Δ -6.40% > 0.5%)
Asset Turnover: 4.95% > 50% (prev 5.86%; Δ -0.91% > 0%)
Interest Coverage Ratio: 0.39 > 6 (EBIT TTM 24.5m / Interest Expense TTM 62.5m)
Altman Z'' -3.33
A: -0.56 (Total Current Assets 920.7m - Total Current Liabilities 2.96b) / Total Assets 3.65b
B: 0.05 (Retained Earnings 182.5m / Total Assets 3.65b)
C: 0.01 (EBIT TTM 24.5m / Avg Total Assets 3.40b)
D: 0.12 (Book Value of Equity 391.8m / Total Liabilities 3.26b)
Altman-Z'' = -3.33 = D
Beneish M -3.67
DSRI: 0.29 (Receivables 4.00m/15.4m, Revenue 168.3m/184.8m)
GMI: 1.11 (GM 66.32% / 59.92%)
AQI: 0.84 (AQ_t 0.74 / AQ_t-1 0.87)
SGI: 0.91 (Revenue 168.3m / 184.8m)
TATA: 0.01 (NI 37.4m - CFO 15.2m) / TA 3.65b)
Beneish M = -3.67 (Cap -4..+1) = AAA
What is the price of CBAN shares?

As of November 20, 2026, the stock is trading at USD 19.61 with a total of 312,645 shares traded. Over the past week, the price has changed by -3.40%, over one month by +0.08%, over three months by -8.00% and over the past year by +24.20%.

Current recommended Stop Loss: 19.00 (which is 3.1% or 1.2 ATR below the current price).

Is CBAN a buy, sell or hold?

Colony Bankcorp has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy CBAN.

  • StrongBuy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the CBAN price?
Analysts Target Price 25.1 28.1%
Colony Bankcorp (CBAN) - Fundamental Data Overview as of 19 November 2026
Market Cap USD = 549.8m (549.8m USD * 1.0 USD.USD)
P/E Trailing = 11.0659
P/E Forward = 11.0011
P/S = 3.5765
P/B = 1.4059
P/EG = 2.1066
Revenue TTM = 168.3m USD
EBIT TTM = 24.5m USD
EBITDA TTM = 28.8m USD
Long Term Debt = 263.2m USD (from longTermDebt, last quarter)
Short Term Debt = 86.4m USD (from shortTermDebt, last fiscal year)
Debt = 263.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -629.3m USD (calculated: Debt 263.2m - CCE 892.5m)
Enterprise Value = 549.8m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.39 (Ebit TTM 24.5m / Interest Expense TTM 62.5m)
EV/FCF = 44.41x (Enterprise Value 549.8m / FCF TTM 12.4m)
FCF Yield = 2.25% (FCF TTM 12.4m / Enterprise Value 549.8m)
FCF Margin = 7.36% (FCF TTM 12.4m / Revenue TTM 168.3m)
Net Margin = 22.24% (Net Income TTM 37.4m / Revenue TTM 168.3m)
Gross Margin = 59.92% ((Revenue TTM 168.3m - Cost of Revenue TTM 67.4m) / Revenue TTM)
Gross Margin QoQ = 68.50% (prev -120.6%)
Tobins Q-Ratio = 0.15 (Enterprise Value 549.8m / Total Assets 3.65b)
Interest Expense / Debt = 23.75% (Interest Expense 62.5m / Debt 263.2m)
Taxrate = 20.48% (9.64m / 47.1m)
NOPAT = 19.5m (EBIT 24.5m * (1 - 20.48%))
Current Ratio = 0.31 (Total Current Assets 920.7m / Total Current Liabilities 2.96b)
Debt / Equity = 0.67 (Debt 263.2m / totalStockholderEquity, last quarter 391.8m)
Debt / EBITDA = -21.82 (Net Debt -629.3m / EBITDA 28.8m)
Debt / FCF = -50.84 (Net Debt -629.3m / FCF TTM 12.4m)
Total Stockholder Equity = 384.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.10% (Net Income 37.4m / Total Assets 3.65b)
RoE = 9.73% (Net Income TTM 37.4m / Total Stockholder Equity 384.5m)
RoCE = 3.79% (EBIT 24.5m / Capital Employed (Equity 384.5m + L.T.Debt 263.2m))
RoIC = 2.54% (NOPAT 19.5m / Invested Capital 768.2m)
WACC = 10.82% (E(549.8m)/V(813.0m) * Re(6.95%) + D(263.2m)/V(813.0m) * Rd(23.75%) * (1-Tc(0.20)))
Discount Rate = 6.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 84.70 | Cagr: 8.80%
[DCF] Terminal Value 64.48% ; FCFF base≈24.8m ; Y1≈21.8m ; Y5≈17.6m
[DCF] Fair Price = 30.43 (EV 201.3m - Net Debt -629.3m = Equity 830.6m / Shares 27.3m; r=10.82% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 98.50 | EPS CAGR: 19.46% | SUE: 0.54 | # QB: 0
Revenue Correlation: 33.09 | Revenue CAGR: 2.46% | SUE: 0.53 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.53 | Chg30d=+1.92% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.07 | Chg30d=+2.48% | Revisions=+25% | GrowthEPS=+15.6% | GrowthRev=+29.5%
EPS next Year (2027-12-31): EPS=2.39 | Chg30d=+0.84% | Revisions=+25% | GrowthEPS=+15.5% | GrowthRev=+33.7%
[Analyst] Revisions Ratio: +50% (up=3, down=0)